Neutrophil/Lymphocyte Ratio and C-Reactive Protein in Patients with COVID-19: Correlations in Deceased and Surviving Patients
Preprint
- 18 October 2024
- preprint
- Published by MDPI AG in Preprints.org
Abstract
COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) associated with inflammatory process activation. Among the elements involved in the inflammatory process are leukocytes and cytokine production. Various studies have determined the importance of the neutrophil-to-lymphocyte ratio (NLR) in different inflammatory processes. C-reactive protein (CRP) is involved in several infectious processes as a marker of inflammation. This study aims to determine the values of NLR and CRP in COVID-19 patients and controls and to determine these values in COVID-19 survivors and deceased patients. Overall, during COVID-19, lymphocyte counts, NLR, and CRP values were significantly increased. Furthermore, it was observed that during the disease, there were more positive correlations between the different inflammatory parameters studied than between the controls. The results show that surviving patients had increased lymphocyte counts and CRP content compared to deceased patients; however, the latter presented the highest NLR values and the lowest lymphocyte values, establishing a prognostic value of severe evolution. The number of significant correlations observed in surviving and deceased patients was similar. This study suggests the importance of leukocytes and CRP in COVID-19 and a possible predictive value for the severe evolution of NLR in the disease.Keywords
All Related Versions
This publication has 28 references indexed in Scilit:
- C‐reactive protein as an effector molecule in Covid‐19 pathogenesisReviews in Medical Virology, 2021
- The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 PneumoniaArchivos de Bronconeumología, 2021
- COVID‐19: Virology, biology and novel laboratory diagnosisThe Journal of Gene Medicine, 2020
- Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysisClinica Chimica Acta, 2020
- Clinical characteristics of 3062 COVID‐19 patients: A meta‐analysisJournal of Medical Virology, 2020
- Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19Journal of Clinical Virology, 2020
- Lymphopenia in COVID‐19: Therapeutic opportunitiesCell Biology International, 2020
- Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19)The Journal of Pathology, 2020
- Neutrophil‐to‐lymphocyte ratio and lymphocyte‐to‐C‐reactive protein ratio in patients with severe coronavirus disease 2019 (COVID‐19): A meta‐analysisJournal of Medical Virology, 2020
- Organ‐protective effect of angiotensin‐converting enzyme 2 and its effect on the prognosis of COVID‐19Journal of Medical Virology, 2020